Moreover, based on the promising results obtained with the high dose of L19-IL2 (100 μg/mouse) in KPC06 mice, we decided to test a lower dose (30 μg/mouse) to evaluate its impact on tumor volume reduction. Here, IL2 is linked to neoplasm.